Isolation and characterization of mesenchymal stem cells and its antitumor application on ovarian cancer cell line
Source abstract
Abstract
The molecular interaction network of Oct-4 (POU5F1) and NANOG connected to regulation and growth of mesenchymal stem cells (MSCs) were supplemented with information of miRNA to find an important micro-RNAs and supplemented molecular interaction network. Following co-culturing of Bone marrow mesenchymal stem cells (BMMSCs) with SKOV3 ovarian cancer cell lines and undifferentiated BMMSCs, MTT was analyzed for cell cytotoxicity. The analyses of the expression of miRNA were performed either after oesteogenesis (hsa-miR-34 and hsa-miR-335) or chondrogenic (hsa-miR-145 and hsa-miR-455) differentiation. This molecular interaction network was imaged in using software. The results from these findings gave an understanding of the main molecular mechanisms regulating MSCs therapeutic activity and their undifferentiated state maintenance. We recommend that the downregulation of miR-335 is crucial role for tissue homeostasis.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: MicroRNA in disease regulation · Mesenchymal stem cell research · Circular RNAs in diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Medical Biotechnology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran;
Department of Medical Biotechnology, Faculty of Advance Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
References (25)
Show source-provided references
1. 10.1016/j.stem.2013.09.00610.1016/j.stem.2013.09.006 ↗
2. 10.1038/cdd.2010.16710.1038/cdd.2010.167 ↗
3. 10.1016/j.smim.2005.01.00110.1016/j.smim.2005.01.001 ↗
4. 10.1677/joe.1.0642610.1677/joe.1.06426 ↗
5. 10.1038/nature0307610.1038/nature03076 ↗
6. 10.1016/j.ymgme.2007.03.01110.1016/j.ymgme.2007.03.011 ↗
7. 10.1016/j.tcb.2006.12.00710.1016/j.tcb.2006.12.007 ↗
8. 10.1016/S0092-8674(04)00045-510.1016/S0092-8674(04)00045-5 ↗
9. 10.1016/j.biochi.2011.07.03210.1016/j.biochi.2011.07.032 ↗
10. 10.1038/nature0331510.1038/nature03315 ↗
11. 10.1101/gr.082701.10810.1101/gr.082701.108 ↗
12. 10.1038/nprot.2008.22110.1038/nprot.2008.221 ↗
13. Hosseinzadeh Shirzeily M · Iran J Reprod Med · 2013 · 11 · 965
14. Rastegar T · Iran J Basic Med Sci · 2013 · 16 · 134
15. Lu L · Haematologica · 2006 · 91 · 1017
16. 10.1111/j.1365-2184.2007.00414.x10.1111/j.1365-2184.2007.00414.x ↗
17. 10.1093/nar/28.18.344210.1093/nar/28.18.3442 ↗
18. 10.1093/nar/gkv35410.1093/nar/gkv354 ↗
19. 10.1101/gr.123930310.1101/gr.1239303 ↗
20. 10.1038/nmeth.348510.1038/nmeth.3485 ↗
21. 10.1371/journal.pone.008216010.1371/journal.pone.0082160 ↗
22. 10.1111/j.1749-6632.2009.04564.x10.1111/j.1749-6632.2009.04564.x ↗
23. 10.1002/stem.119810.1002/stem.1198 ↗
24. 10.1074/jbc.M114.60506310.1074/jbc.M114.605063 ↗
25. 10.1016/j.cell.2005.08.02010.1016/j.cell.2005.08.020 ↗